Caplight Directory>Investors>Panacea Venture Healthcare>Panaceaventure


Panacea Venture Healthcare

Panacea Venture Healthcare

Shanghai, Shanghaipanaceaventure.com

Overview

Panacea Venture is a healthcare private equity firm led by former managing partner of Kleiner Perkins in China, James Huang, and is focused on biotech and pharmaceuticals, medical devices and diagnostics, as well as healthcare IT and services across China, the US, Europe and other major global life sciences hubs. They invest in and incubate early-stage life science companies with breakthrough technologies and discoveries that can potentially address unmet medical needs to enhance the quality of life on a global scale.

Year Founded

2017

Portfolio Companies

16

Investments

CompanyDateStageLead
Kainova TherapeuticsFeb 2026Series BCo-investor
OutSeeJan 2026SeedCo-investor
OutSeeJun 2025SeedCo-investor
Actym TherapeuticsJun 2023Series ACo-investor
Kainova TherapeuticsMay 2022Series ALead
View all investments

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersShanghai, Shanghai
Year Founded2017

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.